DOXOrubicin Hydrochloride Injection recall: Contamination
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake…
Why was DOXOrubicin Hydrochloride Injection recalled?
Cross Contamination with Other Products: trace amounts of octreotide found during testing
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch: 6120525, exp 11/2020
- Product
- DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake…
- Recalling firm
- Fresenius Kabi USA, LLC
- Quantity
- 16,986 vials
- Distribution
- Nationwide USA and Puerto Rico
- Recall date
- December 2, 2020
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)